$NYC
American Strategic Investment Co. Stock $nyc

$nyc Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000159552722000007 Filed on March 18, 2022

Income Statement

Concept	2021 Q4	2021 Q3	2021
Revenue	$24.21M	$300.0K	$70.22M
YoY Change	145.52%	-98.23%	11.64%
Cost Of Revenue	$10.21M	$9.891M	$40.92M
YoY Change	-3.74%	-2.84%	2.65%
Gross Profit	$14.00M	$5.957M	$29.30M
YoY Change	-1966.0%	-12.65%	27.18%
Gross Profit Margin	57.81%	1985.67%	41.73%
Selling, General & Admin	$4.223M	$4.005M	$17.18M
YoY Change	6.64%	35.76%	50.03%
% of Gross Profit	30.18%	67.23%	58.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.657M	$7.851M	$31.06M
YoY Change	-0.3%	-9.13%	-2.18%
% of Gross Profit	54.71%	131.79%	105.99%
Operating Expenses	$11.88M	$11.86M	$48.24M
YoY Change	2.15%	2.3%	11.68%
Operating Profit	$2.115M	-$6.312M	-$20.39M
YoY Change	-117.08%	-12.55%	-9.83%
Interest Expense	-$4.811M	$4.803M	$19.09M
YoY Change	13.74%	-5.62%	-0.26%
% of Operating Profit	-227.47%
Other Income/Expense, Net	$3.000K	-$4.798M	-$19.04M
YoY Change	-70.0%	-5.36%	3.76%
Pretax Income	-$3.732M	-$11.11M	-$39.43M
YoY Change	-77.52%	-9.59%	-3.74%
Income Tax	$23.00K	$14.00K	$37.00K
% Of Pretax Income
Net Earnings	-$3.755M	-$11.12M	-$39.47M
YoY Change	-77.38%	-9.47%	-3.65%
Net Earnings / Revenue	-15.51%	-3708.0%	-56.2%
Basic Earnings Per Share		-$0.85	-$3.05
Diluted Earnings Per Share	-$283.3K	-$0.85	-$3.05
COMMON SHARES
Basic Shares Outstanding	13.28M shares	13.09M shares	12.98M shares
Diluted Shares Outstanding		13.09M shares	12.98M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.67M	$23.17M	$11.67M
YoY Change	-62.34%	-40.74%	-62.34%
Cash & Equivalents	$11.67M	$23.17M	$11.67M
Short-Term Investments
Other Short-Term Assets	$9.293M	$7.398M	$9.293M
YoY Change	-28.52%	-33.35%	-28.52%
Inventory
Prepaid Expenses
Receivables	$25.84M	$24.82M	$25.84M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$46.81M	$55.38M	$46.81M
YoY Change	-29.19%	-26.55%	-29.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$749.9M	$756.1M	$749.9M
YoY Change	-3.4%	-3.46%	-3.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$26.31M	$20.67M	$26.31M
YoY Change	34.9%	7.1%	34.9%
Total Long-Term Assets	$776.2M	$776.8M	$776.2M
YoY Change	-2.45%	-3.21%	-2.44%
TOTAL ASSETS
Total Short-Term Assets	$46.81M	$55.38M	$46.81M
Total Long-Term Assets	$776.2M	$776.8M	$776.2M
Total Assets	$823.1M	$832.1M	$823.1M
YoY Change	-4.5%	-5.22%	-4.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.131M	$6.535M	$8.131M
YoY Change	17.84%	-3.9%	17.84%
Accrued Expenses	$54.77M	$54.78M	$54.77M
YoY Change	-0.05%	-0.03%	-0.05%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$62.90M	$61.32M	$62.90M
YoY Change	1.95%	-0.46%	1.95%
LONG-TERM LIABILITIES
Long-Term Debt	$398.1M	$397.7M	$398.1M
YoY Change	0.38%	0.39%	0.38%
Other Long-Term Liabilities	$10.90M	$19.48M	$10.90M
YoY Change	-50.47%	-17.82%	-50.47%
Total Long-Term Liabilities	$409.0M	$417.2M	$409.0M
YoY Change	-2.29%	-0.64%	-2.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$62.90M	$61.32M	$62.90M
Total Long-Term Liabilities	$409.0M	$417.2M	$409.0M
Total Liabilities	$471.9M	$478.5M	$484.1M
YoY Change	-1.74%	-0.63%	-0.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$350.7M	-$345.6M
YoY Change	14.65%	19.73%
Common Stock	$133.0K	$133.0K
YoY Change	3.1%	3.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$339.0M	$343.6M	$339.0M
YoY Change
Total Liabilities & Shareholders Equity	$823.1M	$832.1M	$823.1M
YoY Change	-4.5%	-5.22%	-4.5%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021
OPERATING ACTIVITIES
Net Income	-$3.755M	-$11.12M	-$39.47M
YoY Change	-77.38%	-9.47%	-3.65%
Depreciation, Depletion And Amortization	$7.657M	$7.851M	$31.06M
YoY Change	-0.3%	-9.13%	-2.18%
Cash From Operating Activities	-$3.605M	$1.086M	-$7.916M
YoY Change	-52.31%	-157.46%	-41.7%
INVESTING ACTIVITIES
Capital Expenditures	-$1.377M	-$884.0K	-$3.375M
YoY Change	129.5%	-48.3%	-10.24%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.377M	-$884.0K	-$3.375M
YoY Change	129.5%	-48.3%	-10.12%
FINANCING ACTIVITIES
Cash Dividend Paid			$5.201M
YoY Change			736.17%
Common Stock Issuance & Retirement, Net			-$5.086M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.370M	568.0K	-$275.0K
YoY Change	114.06%	-272.12%	-71.65%
NET CHANGE
Cash From Operating Activities	-3.605M	1.086M	-$7.916M
Cash From Investing Activities	-1.377M	-884.0K	-$3.375M
Cash From Financing Activities	-1.370M	568.0K	-$275.0K
Net Change In Cash	-6.352M	770.0K	-$11.57M
YoY Change	-27.82%	-119.59%	-36.81%
FREE CASH FLOW
Cash From Operating Activities	-$3.605M	$1.086M	-$7.916M
Capital Expenditures	-$1.377M	-$884.0K	-$3.375M
Free Cash Flow	-$2.228M	$1.970M	-$4.541M
YoY Change	-67.99%	-1194.44%	-53.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001595527
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2020Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.4115
CY2020Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.4115
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39448
CY2021	dei	Entity Registrant Name EntityRegistrantName	New York City REIT, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4380248
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	650 Fifth Ave.
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	30th Floor
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10019
CY2021	dei	City Area Code CityAreaCode	212
CY2021	dei	Local Phone Number LocalPhoneNumber	415-6500
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	127200000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13371811	shares
CY2021	dei	Auditor Firm AuditorFirmId	238
CY2021	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2021	dei	Auditor Location AuditorLocation	New York, New York
CY2021Q4	us-gaap	Land Land	192600000	USD
CY2020Q4	us-gaap	Land Land	193658000	USD
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	572576000	USD
CY2020Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	568861000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	87478000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	98118000	USD
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	852654000	USD
CY2020Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	860637000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	157880000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	139666000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	694774000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	720971000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11674000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30999000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	16754000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8995000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	55167000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	55375000	USD
CY2021Q4	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2020Q4	us-gaap	Due From Affiliates DueFromAffiliates	435000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	9293000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	12953000	USD
CY2021Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	25838000	USD
CY2020Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	22050000	USD
CY2021Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	9551000	USD
CY2020Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	10503000	USD
CY2021Q4	us-gaap	Assets Assets	823051000	USD
CY2020Q4	us-gaap	Assets Assets	861846000	USD
CY2021Q4	nycr	Secured Debt Netof Deferred Financing Costs SecuredDebtNetofDeferredFinancingCosts	398117000	USD
CY2020Q4	nycr	Secured Debt Netof Deferred Financing Costs SecuredDebtNetofDeferredFinancingCosts	396574000	USD
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	141000	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	0	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	8131000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	6916000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54770000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54820000	USD
CY2021Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	4224000	USD
CY2020Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	14006000	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1553000	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	3405000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5120000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4558000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	471915000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	480279000	USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13277738	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12983168	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13277738	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12802690	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12802690	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	133000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	129000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	691118000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	686715000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1553000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3404000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-350709000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-305882000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	338989000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	377558000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	12147000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	4009000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	351136000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	381567000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	823051000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	861846000	USD
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	70219000	USD
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	62895000	USD
CY2019	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	70530000	USD
CY2021	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	7554000	USD
CY2020	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	7577000	USD
CY2019	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	7327000	USD
CY2021	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	33363000	USD
CY2020	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	32283000	USD
CY2019	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	31177000	USD
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	1452000	USD
CY2020	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	USD
CY2019	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	USD
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2019	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	13000	USD
CY2021	nycr	Stock Issuance Expense StockIssuanceExpense	0	USD
CY2020	nycr	Stock Issuance Expense StockIssuanceExpense	1299000	USD
CY2019	nycr	Stock Issuance Expense StockIssuanceExpense	0	USD
CY2021	nycr	Vesting And Conversion Expense VestingAndConversionExpense	0	USD
CY2020	nycr	Vesting And Conversion Expense VestingAndConversionExpense	1153000	USD
CY2019	nycr	Vesting And Conversion Expense VestingAndConversionExpense	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	8475000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	3874000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	86000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8704000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7571000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6346000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31057000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31747000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31161000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	90605000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	85504000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	76110000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-20386000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-22609000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-5580000	USD
CY2021	us-gaap	Interest Expense InterestExpense	19090000	USD
CY2020	us-gaap	Interest Expense InterestExpense	19140000	USD
CY2019	us-gaap	Interest Expense InterestExpense	17157000	USD
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	47000	USD
CY2020	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	787000	USD
CY2019	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	847000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19043000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18353000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16310000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39429000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40962000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21890000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-39466000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-40962000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21890000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	1851000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-2077000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-1327000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37615000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43039000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23217000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12983168	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12767380	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12767380	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12748923	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12748923	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.05
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.05
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.21
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.21
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.72
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.72
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	443680000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	86000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-21890000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1327000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	420549000	USD
CY2020	nycr	Stock Redeemed During Period Value StockRedeemedDuringPeriodValue	328000	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1153000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3874000	USD
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04889
CY2020	us-gaap	Dividends Dividends	622000	USD
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	20000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-40962000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2077000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	381567000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4252000	USD
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	183000	USD
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	0	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8476000	USD
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2021	us-gaap	Dividends Dividends	5201000	USD
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	160000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-39466000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1851000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	351136000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-39466000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-40962000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-21890000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31057000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31747000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31161000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1543000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1543000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1304000	USD
CY2021	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	8671000	USD
CY2020	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	3026000	USD
CY2019	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	1563000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	8475000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	3874000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	86000	USD
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	1452000	USD
CY2020	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	USD
CY2019	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	USD
CY2021	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	-79000	USD
CY2020	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
CY2019	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-1153000	USD
CY2019	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2021	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	3788000	USD
CY2020	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	402000	USD
CY2019	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	5219000	USD
CY2021	nycr	Increase Decrease In Straight Line Rent Payable IncreaseDecreaseInStraightLineRentPayable	109000	USD
CY2020	nycr	Increase Decrease In Straight Line Rent Payable IncreaseDecreaseInStraightLineRentPayable	109000	USD
CY2019	nycr	Increase Decrease In Straight Line Rent Payable IncreaseDecreaseInStraightLineRentPayable	110000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-843000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7377000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1925000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-111000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-545000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2149000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	562000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	308000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1518000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7916000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13578000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1603000	USD
CY2021	us-gaap	Payments To Acquire Other Real Estate PaymentsToAcquireOtherRealEstate	0	USD
CY2020	us-gaap	Payments To Acquire Other Real Estate PaymentsToAcquireOtherRealEstate	0	USD
CY2019	us-gaap	Payments To Acquire Other Real Estate PaymentsToAcquireOtherRealEstate	38265000	USD
CY2021	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	3375000	USD
CY2020	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	3755000	USD
CY2019	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	7709000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3375000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3755000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-45974000	USD
CY2021	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	0	USD
CY2020	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	0	USD
CY2019	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	55000000	USD
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2020	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2019	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3927000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5269000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	5201000	USD
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	622000	USD
CY2019	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2021	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	0	USD
CY2020	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	328000	USD
CY2019	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	0	USD
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	160000	USD
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	20000	USD
CY2019	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	183000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-275000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-970000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51073000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11566000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18303000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3496000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39994000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58297000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54801000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28428000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39994000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58297000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11674000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30999000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51199000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	16754000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8995000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7098000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28428000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39994000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58297000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	17552000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	16721000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	15505000	USD
CY2021	nycr	Noncashor Part Noncash Acquisition Proceeds From Secured Debt Assumed NoncashorPartNoncashAcquisitionProceedsFromSecuredDebtAssumed	0	USD
CY2020	nycr	Noncashor Part Noncash Acquisition Proceeds From Secured Debt Assumed NoncashorPartNoncashAcquisitionProceedsFromSecuredDebtAssumed	0	USD
CY2019	nycr	Noncashor Part Noncash Acquisition Proceeds From Secured Debt Assumed NoncashorPartNoncashAcquisitionProceedsFromSecuredDebtAssumed	51000000	USD
CY2021	nycr	Noncashor Part Noncash Proceedsfrom Mortgage Notes Usedto Acquire Real Estate Investments NoncashorPartNoncashProceedsfromMortgageNotesUsedtoAcquireRealEstateInvestments	0	USD
CY2020	nycr	Noncashor Part Noncash Proceedsfrom Mortgage Notes Usedto Acquire Real Estate Investments NoncashorPartNoncashProceedsfromMortgageNotesUsedtoAcquireRealEstateInvestments	0	USD
CY2019	nycr	Noncashor Part Noncash Proceedsfrom Mortgage Notes Usedto Acquire Real Estate Investments NoncashorPartNoncashProceedsfromMortgageNotesUsedtoAcquireRealEstateInvestments	51000000	USD
CY2021	nycr	Noncashor Part Noncash Accrued Capital Expenditures NoncashorPartNoncashAccruedCapitalExpenditures	1326000	USD
CY2020	nycr	Noncashor Part Noncash Accrued Capital Expenditures NoncashorPartNoncashAccruedCapitalExpenditures	428000	USD
CY2019	nycr	Noncashor Part Noncash Accrued Capital Expenditures NoncashorPartNoncashAccruedCapitalExpenditures	726000	USD
CY2021	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1017000	USD
CY2020	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	0	USD
CY2019	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	0	USD
CY2021Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	8	property
CY2021Q4	us-gaap	Net Rentable Area NetRentableArea	1200000	sqft
CY2021Q4	nycr	Aggregate Purchase Priceof Real Estate AggregatePurchasePriceofRealEstate	790700000	USD
CY2020	nycr	Stock Issuance Expense StockIssuanceExpense	1300000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, and fair value measurements, as applicable.</span></div>
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	USD
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	1400000	USD
CY2021	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s revenues, which are derived primarily from lease contracts, include rents that each tenant pays in accordance with the terms of each lease reported on a straight-line basis over the initial term of the lease. As of December 31, 2021, these leases had a weighted-average remaining lease term of 6.9 years. Because many of the Company’s leases provide for rental increases at specified intervals, straight-line basis accounting requires that the Company record a receivable for, and include in revenue from tenants, unbilled rent receivables that the Company will receive if the tenant makes all rent payments required through the expiration of the initial term of the lease. When the Company acquires a property, the acquisition date is considered to be the commencement date for purposes of this calculation. For new leases after acquisition, the commencement date is considered to be the date the tenant takes control of the space. For lease modifications, the commencement date is considered to be the date the lease modification is executed. The Company defers the revenue related to lease payments received from tenants in advance of their due dates. Pursuant to certain of the Company’s lease agreements, tenants are required to reimburse the Company for certain property operating expenses (recorded in revenue from tenants), in addition to paying base rent, whereas under certain other lease agreements, the tenants are directly responsible for all operating costs of the respective properties. To the extent such costs exceed the applicable tenant’s base year, many but not all of the Company’s leases require the tenant to pay its allocable share of increases in operating expenses, which may include common area maintenance costs, real estate taxes and insurance. Under ASC 842, the Company has elected to report combined lease and non-lease components in a single line “Revenue from tenants”. For expenses paid directly by the tenant, under both ASC 842 and 840, the Company has reflected them on a net basis.</span></div>The Company owns certain properties with leases that include provisions for the tenant to pay contingent rental income based on a percent of the tenant’s sales upon the achievement of certain sales thresholds or other targets which may be monthly, quarterly or annual targets. As the lessor under the aforementioned leases, the Company defers the recognition of contingent rental income, until the specified target that triggered the contingent rental income is achieved, or until such sales upon which percentage rent is based are known. For the years ended December 31, 2021, 2020 and 2019, approximately $0.5 million, $0.1 million and $0.1 million, respectively, in contingent rental income is included in revenue from tenants in the consolidated statements of operations and comprehensive loss. <div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company continually reviews receivables related to rent and unbilled rents receivable and determines collectability by taking into consideration the tenant’s payment history, the financial condition of the tenant, business conditions in the industry in which the tenant operates and economic conditions in the area in which the property is located. Under the leasing standard adopted on January 1, 2019 (see the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“Recently Issued Accounting Pronouncements”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below), the Company is required to assess, based on credit risk, if it is probable that the Company will collect virtually all of the lease payments at the lease commencement date, and it must continue to reassess collectability periodically thereafter based on new facts and circumstances affecting the credit risk of the tenant. In fiscal year ended 2021 and 2020, this assessment has included consideration of the impacts of the COVID-19 pandemic on the Company’s tenant’s ability to pay rents in accordance with their contracts. Partial reserves, or the ability to assume partial recovery are no longer permitted. If the Company determines that it is probable that it will collect virtually all of the lease payments (base rent and additional rent), the lease will continue to be accounted for on an accrual basis (i.e., straight-line). However, if the Company determines it is not probable that it will collect virtually all of the lease payments, the lease will be accounted for on a cash basis and the straight-line rent receivable accrued will be written off, as well as any accounts receivable, where it was subsequently concluded that collection was not probable. Cost recoveries from tenants are included in revenue from tenants, in accordance with current accounting rules, on the accompanying consolidated statements of operations and comprehensive loss in the period the related costs are incurred, as applicable.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In accordance with lease accounting rules the Company records uncollectable amounts as reductions in revenue from tenants. During the year ended December 31, 2020, the Company reduced revenue from tenants by $8.5 million for reserves recorded during the period on receivables for which the related tenants have been put on a cash basis (see accounting policy above). Some of these reductions relate to tenants that terminated their leases early while others relate to leases that have not been paying rent and have been placed on a cash basis in accordance with ASC 842. There were no such reductions recorded for the years ended 2021 or 2019. During the year ended December 31, 2021, no rental income was received from any of the tenants that were previously placed on a cash basis, however, the Company did receive a lease termination fee of $1.4 million from two of the tenants that was placed on a cash basis in 2020 (see below). </span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2021, the Company signed a termination agreement with the parking garage tenants at its 400 E. 67th Street - Laurel Condominium/200 Riverside Boulevard properties. The previous parking garage tenants have vacated the space and new tenants have signed lease agreements with us for the spaces in the fourth quarter of 2021. In addition, the Company recorded a termination fee for a tenant in its 9 Times Square property. These termination agreements required the tenants to pay termination fees aggregating $1.5 million to the Company, which was all received during the fourth quarter of 2021. The termination fees are recorded in revenue from tenants in the consolidated statements of operations and comprehensive loss.</span></div>In the third quarter of 2021, the Company launched Innovate NYC, a co-working company, at 1140 Avenue of the Americas. The Company recorded revenue of approximately $0.3 million from Innovate NYC during the year ended December 31, 2021, which is considered non-lease income.
CY2021	nycr	Lessor Operating Lease Weighted Average Remaining Lease Term LessorOperatingLeaseWeightedAverageRemainingLeaseTerm	P6Y10M24D
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	54196000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	50134000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	48268000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	40934000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	35683000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	199592000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	428807000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	USD
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	1400000	USD
CY2021Q4	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1500000	USD
CY2021Q3	us-gaap	Revenues Revenues	300000	USD
CY2019	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2021	nycr	Gainon Dispositionsof Real Estate Investments GainonDispositionsofRealEstateInvestments	0	USD
CY2019	nycr	Gainon Dispositionsof Real Estate Investments GainonDispositionsofRealEstateInvestments	0	USD
CY2020	nycr	Gainon Dispositionsof Real Estate Investments GainonDispositionsofRealEstateInvestments	0	USD
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1500000	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2019	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may use derivative financial instruments to hedge all or a portion of the interest rate risk associated with its borrowings. Certain of the techniques used to hedge exposure to interest rate fluctuations may also be used to protect against declines in the market value of assets that result from general trends in debt markets. The principal objective of such agreements is to minimize the risks and costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting for subsequent changes in the fair value of these derivatives depends on whether each has been designated and qualifies for hedge accounting treatment. If the Company elects not to apply hedge accounting treatment, any change in the fair value of these derivative instruments is recognized immediately in gains (losses) on derivative instruments in the accompanying consolidated statements of operations and comprehensive loss. If the derivative is designated and qualifies for hedge accounting treatment, the change in the estimated fair value of the derivative is recorded in other comprehensive income (loss) to the extent that it is effective with any ineffective portion of a derivative’s change in fair value will be immediately recognized in earnings. After the adoption of ASU 2017-12, if the derivative qualified for hedge accounting, all the change in value is recorded in other comprehensive income.</span></div>
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28400000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40000000	USD
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	26300000	USD
CY2020Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	38200000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37000	USD
CY2020	nycr	Reit Taxable Income REITTaxableIncome	0	USD
CY2021	nycr	Reit Taxable Income REITTaxableIncome	0	USD
CY2019	nycr	Reit Taxable Income REITTaxableIncome	0	USD
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04889
CY2021Q4	nycr	Uncertain Tax Positions UncertainTaxPositions	0	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	54900000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54900000	USD
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1500000	USD
CY2019	nycr	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Land Acquiredin Period BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLandAcquiredinPeriod	55548000	USD
CY2019	nycr	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Property Plantand Equipment Acquired In Period BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentAcquiredInPeriod	24324000	USD
CY2019	nycr	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Tangible Assets Acquired During Period BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAcquiredDuringPeriod	79872000	USD
CY2019	nycr	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Intangible Assets Acquired During The Period BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsAcquiredDuringThePeriod	9393000	USD
CY2019	nycr	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Assets Acquired Netof Liabilities Assumed In Period BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredNetofLiabilitiesAssumedInPeriod	89265000	USD
CY2019	nycr	Business Combination Assetsand Liabilities Assumed Mortgage Proceeds BusinessCombinationAssetsandLiabilitiesAssumedMortgageProceeds	51000000	USD
CY2019	nycr	Business Acquisition Cost Of Acquired Entity Cash Paid In Period BusinessAcquisitionCostOfAcquiredEntityCashPaidInPeriod	38265000	USD
CY2019	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	1	property
CY2019	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P13Y4M24D
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	87478000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	45239000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	42239000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	98118000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	47195000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	50923000	USD
CY2021Q4	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	13275000	USD
CY2021Q4	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	9051000	USD
CY2021Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	4224000	USD
CY2020Q4	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	25941000	USD
CY2020Q4	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	11935000	USD
CY2020Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	14006000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5376000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4137000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3386000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2140000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1381000	USD
CY2021Q4	nycr	Amortization Income Net Next Twelve Months AmortizationIncomeNetNextTwelveMonths	244000	USD
CY2021Q4	nycr	Amortization Income Net Year Two AmortizationIncomeNetYearTwo	167000	USD
CY2021Q4	nycr	Amortization Income Net Year Three AmortizationIncomeNetYearThree	467000	USD
CY2021Q4	nycr	Amortization Income Net Year Four AmortizationIncomeNetYearFour	333000	USD
CY2021Q4	nycr	Amortization Income Net Year Five AmortizationIncomeNetYearFive	45000	USD
CY2019Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0385
CY2021Q4	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	834300000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5500000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	49500000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	99000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	251000000	USD
CY2021Q4	us-gaap	Secured Debt SecuredDebt	405000000	USD
CY2021	nycr	Termination Fees TerminationFees	1400000	USD
CY2021	nycr	Termination Fees TerminationFees	1400000	USD
CY2019Q1	us-gaap	Derivative Term Of Contract DerivativeTermOfContract	P5Y
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	0	USD
CY2021Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	1553000	USD
CY2021Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1553000	USD
CY2021Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2021Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	1553000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	0	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	3405000	USD
CY2020Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	3405000	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	3405000	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	1700000	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	1700000	USD
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13300000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12800000	shares
CY2021	nycr	Common Stock Dividends Per Share Declared Annualized CommonStockDividendsPerShareDeclaredAnnualized	0.40
CY2021Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
CY2020Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04889
CY2021Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04889
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	6672	shares
CY2020Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	300000	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1200000	USD
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P45Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.086
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	55200000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54800000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	4700000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	4700000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	4700000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	4900000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	4900000	USD
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	4900000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4746000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4746000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4746000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4746000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	4746000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	197754000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	221484000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	166714000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54770000	USD
CY2021	nycr	Advisory Agreement Renewal Term AdvisoryAgreementRenewalTerm	P5Y
CY2018Q4	nycr	Period Prior To Expiration Date Needed To Terminate Agreement PeriodPriorToExpirationDateNeededToTerminateAgreement	P180D
CY2021	nycr	Related Party Transaction Asset Management Fee Percentageof Benchmark RelatedPartyTransactionAssetManagementFeePercentageofBenchmark	0.0125
CY2020	nycr	Vesting And Conversion Expense VestingAndConversionExpense	1200000	USD
CY2021Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	-141000	USD
CY2020Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	435000	USD
CY2021Q3	us-gaap	Due To Other Related Parties Current And Noncurrent DueToOtherRelatedPartiesCurrentAndNoncurrent	400000	USD
CY2021	nycr	Consecutive Trading Dates Commencing Converted Shares ConsecutiveTradingDatesCommencingConvertedShares	P180D
CY2021Q4	nycr	Common Stock Shares Authorized For Grant Percentage CommonStockSharesAuthorizedForGrantPercentage	0.200
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8400000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3800000	USD
CY2021	nycr	Distributions On The Ltip Unit DistributionsOnTheLTIPUnit	0.10
CY2021	nycr	Distribution On The Earned Ltip Unit DistributionOnTheEarnedLTIPUnit	0.90
CY2021	nycr	Number Subjects To Awards That Reduce Shares Available Ratio NumberSubjectsToAwardsThatReduceSharesAvailableRatio	1	shares
CY2019	nycr	Sharebased Compensation Arrangementby Sharebased Payment Award Shares Issuedin Period In Lieu Of Cash SharebasedCompensationArrangementbySharebasedPaymentAwardSharesIssuedinPeriodInLieuOfCash	0	shares
CY2020	nycr	Sharebased Compensation Arrangementby Sharebased Payment Award Shares Issuedin Period In Lieu Of Cash SharebasedCompensationArrangementbySharebasedPaymentAwardSharesIssuedinPeriodInLieuOfCash	0	shares
CY2021	nycr	Sharebased Compensation Arrangementby Sharebased Payment Award Shares Issuedin Period In Lieu Of Cash SharebasedCompensationArrangementbySharebasedPaymentAwardSharesIssuedinPeriodInLieuOfCash	0	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-39466000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-40962000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-21890000	USD
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	-160000	USD
CY2020	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2019	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-39626000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-40962000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-21890000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12983168	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12983168	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12767380	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12767380	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12748923	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12748923	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.05
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.05
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.21
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.21
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.72
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.72
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4035842	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1071314	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	70933	shares
CY2021Q4	srt	Real Estate And Accumulated Depreciation Amount Of Encumbrances RealEstateAndAccumulatedDepreciationAmountOfEncumbrances	405000000	USD
CY2021Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Land RealEstateAndAccumulatedDepreciationInitialCostOfLand	193658000	USD
CY2021Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements	504536000	USD
CY2021Q4	us-gaap	Sec Schedule Iii Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Buildings And Improvements SECScheduleIIIRealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionBuildingsAndImprovements	66982000	USD
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	765176000	USD
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	112641000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	87500000	USD
CY2021Q4	srt	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	727800000	USD
CY2021Q4	nycr	Finite Lived Intangible Assetsand Liabilities Accumulated Amortization FiniteLivedIntangibleAssetsandLiabilitiesAccumulatedAmortization	45200000	USD
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	762519000	USD
CY2019Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	759487000	USD
CY2018Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	671210000	USD
CY2021	nycr	Real Estate Investment Property At Cost Acquisitions RealEstateInvestmentPropertyAtCostAcquisitions	0	USD
CY2020	nycr	Real Estate Investment Property At Cost Acquisitions RealEstateInvestmentPropertyAtCostAcquisitions	0	USD
CY2019	nycr	Real Estate Investment Property At Cost Acquisitions RealEstateInvestmentPropertyAtCostAcquisitions	79872000	USD
CY2021	us-gaap	Real Estate Improvements RealEstateImprovements	4701000	USD
CY2020	us-gaap	Real Estate Improvements RealEstateImprovements	3032000	USD
CY2019	us-gaap	Real Estate Improvements RealEstateImprovements	8405000	USD
CY2021	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	1452000	USD
CY2020	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	0	USD
CY2019	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	0	USD
CY2021	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	592000	USD
CY2020	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	USD
CY2019	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	USD
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	765176000	USD
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	762519000	USD
CY2019Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	759487000	USD
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	92470000	USD
CY2019Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	72656000	USD
CY2018Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	53449000	USD
CY2021	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	20684000	USD
CY2020	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	19814000	USD
CY2019	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	19207000	USD
CY2021	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	513000	USD
CY2020	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	0	USD
CY2019	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	0	USD
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	112641000	USD
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	92470000	USD
CY2019Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	72656000	USD

Files In Submission

Name	View Source	Status
0001595527-22-000007-index-headers.html	Edgar Link	pending
0001595527-22-000007-index.html	Edgar Link	pending
0001595527-22-000007.txt	Edgar Link	pending
0001595527-22-000007-xbrl.zip	Edgar Link	pending
ex1030formofrestrictedshar.htm	Edgar Link	pending
ex1031formofrestrictedshar.htm	Edgar Link	pending
ex211nycrsubsidiarylist123.htm	Edgar Link	pending
ex231nycrpwcconsent123121.htm	Edgar Link	pending
ex311nycrceocertification1.htm	Edgar Link	pending
ex312nycrcfocertification1.htm	Edgar Link	pending
ex32ceoandcfocertification.htm	Edgar Link	pending
ex39nycrarticlessupplement.htm	Edgar Link	pending
ex44nycr-descriptionofsecu.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nycr-20211231.htm	Edgar Link	pending
nycr-20211231.xsd	Edgar Link	pending
nycr-20211231_cal.xml	Edgar Link	unprocessable
nycr-20211231_def.xml	Edgar Link	unprocessable
nycr-20211231_g1.jpg	Edgar Link	pending
nycr-20211231_g2.jpg	Edgar Link	pending
nycr-20211231_htm.xml	Edgar Link	completed
nycr-20211231_lab.xml	Edgar Link	unprocessable
nycr-20211231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NYC
American Strategic Investment Co. Stock $nyc

2021 Q4 Form 10-K Financial Statement

#000159552722000007 Filed on March 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NYC American Strategic Investment Co. Stock $nyc

2021 Q4 Form 10-K Financial Statement

#000159552722000007 Filed on March 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NYC
American Strategic Investment Co. Stock $nyc